US Nuclear (UCLE) 10-Q 20 Nov 23 2023 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Nov. 15, 2023
Document Information Line Items
Entity Registrant Name	US NUCLEAR CORP.
Trading Symbol	UCLE
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		38,805,778
Amendment Flag	false
Entity Central Index Key	0001543623
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-54617
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-4535739
Entity Address, Address Line One	7051 Eton Avenue
Entity Address, City or Town	Canoga Park
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	91303
City Area Code	(818)
Local Phone Number	883-7043
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock $0.0001 par value
Security Exchange Name	NONE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash	$ 184,703	$ 126,109
Accounts receivable, net	242,354	329,858
Note receivable	18,250
Inventories	2,064,116	2,024,664
Prepaid expenses and other current assets		26,370
TOTAL CURRENT ASSETS	2,509,423	2,507,001
Property and equipment, net	4,158	6,501
Investments	4,539	10,059
Acquisition deposit	15,000	15,000
Goodwill	570,176	570,176
TOTAL ASSETS	3,103,296	3,108,737
CURRENT LIABILITIES
Accounts payable	179,753	100,398
Accrued liabilities	794,765	688,422
Accrued compensation - officers	895,000	695,000
Customer deposit	12,897	88,694
Notes payable	5,272	9,574
Convertible debt, net of debt discount	711,253	412,953
Note payable to shareholder	1,056,695	874,679
Line of credit	311,273	307,321
TOTAL CURRENT LIABILITIES	4,372,908	3,457,041
TOTAL LIABILITIES	4,372,908	3,457,041
COMMITMENTS AND CONTINGENICES
SHAREHOLDERS’ EQUITY:
Common stock, $0.0001 par value; 100,000,000 shares authorized, 38,095,778 and 31,621,242 shares issued and outstanding	3,810	3,162
Common shares to be issued		39,000
Additional paid in capital	16,155,572	14,740,401
Accumulated deficit	(17,428,994)	(15,130,867)
TOTAL SHAREHOLDERS’ EQUITY	(1,269,612)	(348,304)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	3,103,296	3,108,737
Related Party
CURRENT LIABILITIES
Accounts payable	$ 406,000	$ 280,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	38,095,778	31,621,242
Common stock, shares outstanding	38,095,778	31,621,242

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Sales	$ 593,502	$ 617,434	$ 1,588,009	$ 1,539,517
Cost of sales	127,727	405,471	651,992	837,523
Gross profit	465,775	211,963	936,017	701,994
Operating expenses
Selling, general and administrative expenses	539,337	695,381	1,875,583	2,103,637
Total operating expenses	539,337	695,381	1,875,583	2,103,637
Loss from operations	(73,562)	(483,419)	(939,565)	(1,401,644)
Other income (expense)
Interest expense	(27,795)	(31,710)	(70,635)	(37,650)
Equity loss in investment			(8,059)
Loss on deconsolidation			(2,539)
Amortization of debt discount	(658,705)	(140,693)	(1,275,316)	(232,449)
Total other income (expense)	(686,500)	(172,403)	(1,356,549)	(270,099)
Loss before provision for income taxes	(760,062)	(655,822)	(2,296,114)	(1,671,743)
Provision for income taxes
Net loss	(760,062)	(655,822)	(2,296,114)	(1,671,743)
Deemed dividend for down-round provision in warrants			(2,013)	(9,652)
Net loss attributed to common stockholders	$ (760,062)	$ (655,822)	$ (2,298,127)	$ (1,681,395)
Weighted average shares outstanding - basic (in Shares)	36,237,707	29,504,433	35,049,921	28,923,132
Loss per shares - basic (in Dollars per share)	$ (0.02)	$ (0.02)	$ (0.07)	$ (0.06)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Weighted average shares outstanding - diluted	36,237,707	29,504,433	35,049,921	28,923,132
Loss per shares - diluted	$ (0.02)	$ (0.02)	$ (0.07)	$ (0.06)

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Changes in Shareholders' Equity (Unaudited) - USD ($)	Common Stock	Common Stock Payable	Additional Paid In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 2,835		$ 13,508,582	$ (13,070,148)	$ 441,269
Balance (in Shares) at Dec. 31, 2021	28,353,215
Issuance of common stock for services	$ 8		22,492		22,500
Issuance of common stock for services (in Shares)	75,000
Net loss				(649,643)	(649,643)
Balance at Mar. 31, 2022	$ 2,843		13,531,074	(13,719,791)	(185,874)
Balance (in Shares) at Mar. 31, 2022	28,428,215
Balance at Dec. 31, 2021	$ 2,835		13,508,582	(13,070,148)	$ 441,269
Balance (in Shares) at Dec. 31, 2021	28,353,215
Issuance of common stock for debt and interest (in Shares)					400,000
Net loss					$ (1,671,743)
Balance at Sep. 30, 2022	$ 3,016		14,168,261	(14,751,543)	(580,266)
Balance (in Shares) at Sep. 30, 2022	30,164,020
Balance at Mar. 31, 2022	$ 2,843		13,531,074	(13,719,791)	(185,874)
Balance (in Shares) at Mar. 31, 2022	28,428,215
Issuance of common stock for loan incentive	$ 62		99,957		100,019
Issuance of common stock for loan incentive (in Shares)	625,000
Convertible debt, net of debt discounts			311,519		311,519
Issuance of common stock for services	$ 36		57,709		57,745
Issuance of common stock for services (in Shares)	360,805
Deemed dividend for down round provision in warrants			9,652	(9,652)
Net loss				(366,278)	(366,278)
Balance at Jun. 30, 2022	$ 2,941		14,009,911	(14,095,721)	(82,869)
Balance (in Shares) at Jun. 30, 2022	29,414,020
Issuance of common stock for services	$ 35		78,390		78,425
Issuance of common stock for services (in Shares)	350,000
Issuance of common stock for debt and interest	$ 40		79,960		80,000
Issuance of common stock for debt and interest (in Shares)	400,000
Net loss				(655,822)	(655,822)
Balance at Sep. 30, 2022	$ 3,016		14,168,261	(14,751,543)	(580,266)
Balance (in Shares) at Sep. 30, 2022	30,164,020
Balance at Dec. 31, 2022	$ 3,162	39,000	14,740,401	(15,130,867)	(348,304)
Balance (in Shares) at Dec. 31, 2022	31,621,242
Issuance of common stock for services	$ 188		224,163		224,350
Issuance of common stock for services (in Shares)	1,875,000
Issuance of common stock for debt and interest	$ 80		119,920		120,000
Issuance of common stock for debt and interest (in Shares)	800,000
Deemed dividend for down round provision in warrants			2,013	(2,013)
Common shares to be issued for services	$ 26	(39,000)	38,974
Common shares to be issued for services (in Shares)	260,000
Additional BCF discount for down round provision on notes			122,531		122,531
Investment in Averox			2,539		2,539
Net loss				(664,534)	(664,534)
Balance at Mar. 31, 2023	$ 3,456		15,250,540	(15,797,414)	(543,418)
Balance (in Shares) at Mar. 31, 2023	34,556,242
Balance at Dec. 31, 2022	$ 3,162	39,000	14,740,401	(15,130,867)	(348,304)
Balance (in Shares) at Dec. 31, 2022	31,621,242
Net loss					(2,296,114)
Balance at Sep. 30, 2023	$ 3,810		16,155,572	(17,428,994)	(1,269,612)
Balance (in Shares) at Sep. 30, 2023	38,095,778
Balance at Mar. 31, 2023	$ 3,456		15,250,540	(15,797,414)	(543,418)
Balance (in Shares) at Mar. 31, 2023	34,556,242
Issuance of common stock for services	$ 55		51,986		52,040
Issuance of common stock for services (in Shares)	545,000
Cashless exercise of warrants	$ 129		(129)
Cashless exercise of warrants (in Shares)	1,289,236
Additional BCF discount for down round provision on notes			204,204		204,204
Net loss				(871,518)	(871,518)
Balance at Jun. 30, 2023	$ 3,639		15,506,601	(16,668,932)	(1,158,692)
Balance (in Shares) at Jun. 30, 2023	36,390,478
Issuance of common stock for services	$ 171		110,536		110,707
Issuance of common stock for services (in Shares)	1,705,300
Additional BCF discount for down round provision on notes			538,435		538,435
Net loss				(760,062)	(760,062)
Balance at Sep. 30, 2023	$ 3,810		$ 16,155,572	$ (17,428,994)	$ (1,269,612)
Balance (in Shares) at Sep. 30, 2023	38,095,778

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES
Net loss	$ (2,296,114)	$ (1,671,743)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,344	15,920
Issuance of common stock for services	387,097	198,696
Debt discount amortization	1,275,316	232,449
Financing costs	3,500	3,500
Loss on deconsolidation	2,539
Equity loss in investment	8,059
Changes in operating assets and liabilities:
Accounts receivable	87,504	(9,940)
Note receivable
Inventories	(39,453)	(1,787)
Prepaid	26,370	(12,620)
Accounts payable	79,355	145,836
Accounts payable - related parties	126,000
Accrued liabilities	110,997	74,905
Accrued compensation - officers	200,000	155,000
Customer deposits	(75,797)	(14,438)
Operating lease liability
Net cash used in operating activities	(102,283)	(884,222)
INVESTING ACTIVITIES
Purchase of property and equipment		(12,986)
Cash paid for investment	(2,539)
Note receivable	(18,250)
Net cash used in investing activities	(20,789)	(12,986)
FINANCING ACTIVITIES
Net borrowings (repayments) under lines of credit	3,952	35,272
Net proceeds from issuance of note payable shareholder	182,016	267,786
Proceeds from convertible note payable		611,000
Repayments of notes payable	(4,302)	(29,666)
Net cash provided by financing activities	181,666	884,392
NET INCREASE (DECREASE) IN CASH	58,594	(12,816)
CASH
Beginning of period	126,109	246,317
End of period	184,703	233,501
Supplemental disclosures of cash flow information
Taxes paid
Interest paid	27	5,940
Non-cash disclosures:
Common stock issued for conversion of debt and interest	120,000	80,000
Original issue debt discount		550,538
Deemed dividend on down round provision	2,013
Additional beneficial conversion feature on down round provision	$ 865,170

Organization

Organization	9 Months Ended
	Sep. 30, 2023
Organization [Abstract]
Organization	Note 1 – Organization Organization and Line of Business US Nuclear Corp., formerly known as APEX 3, Inc., (the “Company” or “US Nuclear”) was incorporated under the laws of the State of Delaware on February 14, 2012. On May 31, 2016, the Company entered into an Asset Purchase Agreement with Electronic Control Concepts (“ECC”) whereby the Company purchased certain tangible and intangible assets of ECC. The Company is engaged in developing, manufacturing, and selling radiation detection and measuring equipment. The Company markets and sells its products to consumers throughout the world.

Basis Presentation

Basis Presentation	9 Months Ended
	Sep. 30, 2023
Basis Presentation [Abstract]
Basis Presentation	Note 2 – Basis Presentation Interim financial statements The unaudited interim financial statements included herein, presented in accordance with United States generally accepted accounting principles and stated in US dollars, have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosure normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosure is adequate to make the information presented not misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with the financial statements of the Company for the year ended December 31, 2022, and notes thereto included in the Company’s annual report on Form 10-K filed on May 12, 2023. The Company follows the same accounting policies in the preparation of interim reports. Results of operations for the interim period are not indicative of annual results. Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company recorded a net loss of $2,296,114 for the nine months ended September 30, 2023, and had an accumulated deficit of $17,428,994 as of September 30, 2023, which raises substantial doubt about its ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries which include Optron, Overhoff Technology Corporation (“Overhoff”), and its wholly owned subsidiary, Electronic Control Concepts (“ECC”), have been prepared in conformity with accounting principles generally accepted in the United States of America. All significant intercompany transactions and balances have been eliminated. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved. Cash and Cash Equivalents Cash and cash equivalents include cash on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. There were no cash equivalents as of September 30, 2023, and December 31, 2022. Concentration of credit risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents. The Company places its cash with high quality financial institutions and at times may exceed the FDIC insurance limit. The Company has not and does not anticipate incurring any losses related to this credit risk. Accounts Receivable The Company maintains reserves for potential credit losses for accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded based on the Company’s historical collection history. Allowance for doubtful accounts as of September 30, 2023, and December 31, 2022, were $5,000 and $5,000, respectively. Inventories Inventories are valued at the lower of cost (determined primarily by the average cost method) or net realizable value. Management compares the cost of inventories with the net realizable value and allowance is made for writing down their inventories to net realizable value, if lower. As of September 30, 2023, and December 31, 2022, there was no allowance for slow moving or obsolete inventory. The Company periodically assessed its inventory for slow moving and/or obsolete items. If any are identified an appropriate allowance for those items is made and/or the items are deemed to be impaired. Property and Equipment Property and Equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of equipment is provided using the straight-line method for substantially all assets with estimated lives as follows: Furniture and fixtures 5 years Leasehold improvement Lesser of lease life or economic life Equipment 5 years Computers and software 5 years Long-Lived Assets The Company applies the provisions of Accounting Standards Codification (“ASC”) Topic 360, Property, Plant, and Equipment Goodwill Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. The entire goodwill balance in the accompanying financial statements resulted from the Company’s acquisition of Overhoff Technology Corporation in 2006. The Company complies with ASC 350, Goodwill and Other Indefinite Lived Intangible Assets Derivative Financial Instruments The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of September 30, 2023, and December 31, 2022, there are no derivative liabilities associated with our convertible notes payable. Investments The Company accounts for investments in equity securities without a readily determinable fair value at cost, minus impairment. If the Company identifies observable price changes in orderly transactions for the identical or a similar investment of the same issuer, the Company measures the equity security at fair value as of the date that the observable transaction occurred (“the measurement alternative”) in accordance with ASC 321. The Company accounts for investments for which it owns 20% or more, but less than 50% on the equity method in accordance with ASC 323. Fair Value of Financial Instruments For certain of the Company’s financial instruments, including cash, accounts receivable, accounts payable, accrued liabilities, customer deposits, and line of credit, the carrying amounts approximate their fair values due to their short maturities. In addition, the Company has a note payable to a shareholder that the carrying amount also approximates fair value. Revenue Recognition Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers Topic 606 Topic 606. Topic 605, Revenue Recognition Revenues from product sales are recognized under Topic 606 ● executed contracts with the Company’s customers that it believes are legally enforceable; ● identification of performance obligations in the respective contract; ● determination of the transaction price for each performance obligation in the respective contract; ● allocation the transaction price to each performance obligation; and ● recognition of revenue only when the Company satisfies each performance obligation. These five elements, as applied to each of the Company’s revenue category, is summarized below: ● Product sales - revenue is recognized when the Company performs its obligations under the contracts it has with its customers to deliver products at an agreed upon price and it is generally when the control of the product has been transferred to the customer. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as customer deposits. Sales returns and allowances was $0 for the nine months ended September 30, 2023, and 2022. The Company provides a one-year warranty on all sales. Warranty expense for the nine months ended September 30, 2023, and 2022 was insignificant. The Company does not provide unconditional right of return, price protection or any other concessions to its customers. See Notes 12 and 13 for disclosures of revenue disaggregated by geographical area and product line. Customer Deposits Customer deposits represent cash paid to the Company by customers before the product has been completed and shipped. Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The adoption had no effect on the Company’s consolidated financial statements. Stock-Based Compensation The Company records stock-based compensation in accordance with FASB ASC Topic 718, “ Compensation – Stock Compensation Basic and Diluted Earnings Per Share Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share Segment Reporting FASB ASC Topic 280, Segment Reporting Related Parties The Company accounts for related party transactions in accordance with ASC 850, Related Party Disclosures Reclassifications Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or stockholders’ equity. Recent Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity

Inventories

Inventories	9 Months Ended
	Sep. 30, 2023
Inventories [Abstract]
Inventories	Note 3 – Inventories Inventories at September 30, 2023 and December 31, 2022 consisted of the following: September 30, December 31, 2023 2022 Raw materials $ 968,162 $ 1,244,880 Work in Progress 91,069 409,637 Finished goods 1,004,885 370,127 Total inventories $ 2,064,116 $ 2,024,664 At September 30, 2023 and December 31, 2022, the inventory reserve was $0.

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2023
Property and Equipment [Abstract]
Property and Equipment	Note 4 – Property and Equipment The following are the details of the property and equipment at September 30, 2023 and December 31, 2022: September 30, December 31, 2023 2022 Furniture and fixtures $ 148,033 $ 148,033 Leasehold Improvements 50,091 50,091 Equipment 237,418 237,418 Computers and software 39,482 39,482 475,024 475,024 Less accumulated depreciation (470,866 ) (468,523 ) Property and equipment, net $ 4,158 $ 6,501 Depreciation expense for the nine months ended September 30, 2023, and 2022 was $2,343 and $2,135 respectively.

Investments

Investments	9 Months Ended
	Sep. 30, 2023
Investments [Abstract]
Investments	Note 5 – Investments MIFTEC On August 3, 2018, the Company closed an agreement by and among, MIFTEC Laboratories, Inc. (“MIFTEC”), a licensee of Magneto-Inertial Fusion Technologies, Inc., (“MIFTI”), and the Company. MIFTEC is a licensee of MIFTI radionuclide technology. MIFTEC will engage the Company to manufacture equipment pursuant to MIFTEC’s specifications and designs and have the Company as a sales representative for the manufactured equipment. The Company will be the exclusive manufacturer and supplier to MIFTEC of equipment in North America and Asia. In addition, the Company received a 10% ownership interest in MIFTEC. The consideration for the exclusive manufacturing rights and a 10% ownership interest in MIFTEC was $500,000 and 300,000 shares of the Company’s common stock valued at $594,000. The fair value was determined based on the Company’s stock price on August 3, 2018. The Company recorded the value of the 10% interest in MIFTEC at $10,000 and recorded $1,084,000 as the acquisition of manufacturing and supply rights in the accompanying consolidated statement of operations during the year ended December 31, 2018. The Company evaluated this investment for impairment and determined that an impairment of $9,000 was necessary during the year ended December 31, 2019. The carrying value of this investment at September 30, 2023, and December 31, 2022 was $1,000 and $1,000, respectively. MIFTI In April 2019, the Company also entered into a Cooperative Agreement with MIFTI whereby the Company acquired certain exclusive manufacturing and supply rights, including thermonuclear fusion-powered reactor for production of electricity per MIFTI designs in return for $500,000, of which $100,000 is payable upon signing, $200,000 within four months of the agreement and $200,000 within nine months of the agreement. The $500,000 is an option to buy a 10% interest in MIFTI for $2,700,000, if completed within 24 months of the agreement date. If the options expire, MIFTI shall issue the Company 500,000 shares of common stock and rescind all other exclusive rights contained in the agreement. The option was rescinded, and the Company received 500,000 shares of MIFTI common stock which represents an ownership of approximately 0.56% for its $500,000 investment. The Company evaluated this investment for impairment and determined that an impairment of $499,000 was necessary during the year ended December 31, 2019. The carrying value of this investment at September 30, 2023 and December 31, 2022 was $1,000 and $1,000, respectively. Grapheton On February 5, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Grapheton, Inc., a California corporation (“Grapheton”). The transaction was closed on March 12, 2020. Grapheton is a start-up company that focuses on building energy storage devices, known as supercapacitors, from a new material system. The technology utilized by Grapheton has been proven to provide a compelling advantage in microelectrode arrays with superior electrical and electrochemical properties. Pursuant to the terms of the SPA, the Corporation will acquire a total of 2,552 shares of Grapheton’s common stock over a two-year period. At closing, the Company was issued a total of 1,452 shares of Grapheton’s common stock for $235,000 and 858,896 shares of the Company’s common stock valued at $601,227. In connection with the SPA, during the second quarter of 2021 the Company received an additional 1,100 shares of Grapheton’s common stock in exchange for the Company’s issuing an additional 1,121,071 shares of common stock valued at $633,405. In addition, Grapheton fulfilled its requirements under the earn out provision and the Company is obligated to make the first earn out payment of $192,500. This amount is recorded as accrued expense in the accompanying consolidated balance sheet. An additional “true up” issuance of the Company’s common stock to Grapheton may be made on the second anniversary of the closing of the SPA, based on the valuation of the Company’s common stock on that date by a third-party valuator. The Company currently owns 35.8% of Grapheton and accounts for its investment in Grapheton using the equity method of accounting in accordance with ASC 323. The Company evaluated this investment and recorded a loss attributed to equity investment of $8,059 during the nine months ended September 30, 2023, and $0 during the nine months ended September 30, 2022. Averox On March 3, 2023, the Company divested itself of its wholly owned subsidiary, Cali From Above, through a Membership Interest Purchase Agreement with the Company’s President and Chief Executive Officer, Robert Goldstein. Consideration received by the Company was 65,000,000 shares of Averox, Inc. (OTC:AVRI), resulting in the Company owning 26% of the issued and outstanding shares of common stock of AVRI. The Company and Cali From Above also signed a Cooperation Agreement whereby the Company holds exclusive sourcing and manufacturing rights for Cali From Above products, thus making Cali From Above a new customer of the Company. The Company accounts for its investment in Averox using the equity method of accounting in accordance with ASC 323. See Note 15.

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2023
Notes Payable [Abstract]
Notes Payable	Note 6 – Notes Payable In connection with the acquisition of assets from ECC, the Company issued a note payable to the owner of ECC. The note accrued interest at 5% per annum, requires quarterly principal and interest payments of $4,518 and is due on April 15, 2021. At September 30, 2023 and December 31, 2022, the amount outstanding under this note payable was $5,272 and $5,272, respectively. The Company repaid $0 during the nine months ended September 30, 2023. On December 26, 2020, a line of credit held by the company had matured, and based on the terms of the line of credit agreement was converted to a note payable upon demand. The obligation accrues interest at the rate of $10.89 per day until the bank receives full payment. As of September 30, 2023, the balance owed by the Company was $0. On May 5, 2022, the Company received a loan in connection with the issuance of stock warrants in the amount of $750,000. The loan has terms of 12 months and accrues interest at 5% per annum. As part of the issuance of the loan, the company identified debt discounts related to the warrants issued, the incentive shares issued as discussed at Note 10, the beneficial conversion feature of the debt, and the expenses paid as part of the issuance. Total debt discounts recorded as of the date of the note was $550,538. As of September 30, 2023, and pursuant to the down-round provision of the note and associated warrants, the Company reevaluated the beneficial conversion feature which resulted in additional debt discount recorded of $578,712. The total remaining unamortized debt discount on this note as of September 30, 2023, is $0. Since the note matured during the period on May 5, 2023, and the note has not been satisfied, the Company will begin accruing interest at the default rate of 16%. On October 10, 2022, the Company received a loan in connection with the issuance of stock warrants in the amount of $375,000. The loan has terms of 12 months and accrues interest at 5% per annum. As part of the issuance of the loan, the company identified debt discounts related to the warrants issued, the beneficial conversion feature of the debt, and the expenses paid as part of the issuance. Total debt discounts recorded as of the date of the note was $200,488. As of September 30, 2023, and pursuant to the down-round provision of the note and associated warrants, the Company reevaluated the beneficial conversion feature recorded which resulted in additional debt discount recorded of $589,545. The total debt discount amortization recorded on the Company’s notes for the nine months ended September 30, 2023, was $1,275,316. Future maturities of all notes payable, net of any debt discounts as of September 30, 2023, are as follows: Years ended December 31, 2023 $ 716,525 2024 - 2025 - 2026 - 2027 - Thereafter - $ 716,525

Note Payable to Shareholder

Note Payable to Shareholder	9 Months Ended
	Sep. 30, 2023
Note Payable to Shareholder [Abstract]
Note Payable to Shareholder	Note 7 – Note Payable to Shareholder Robert Goldstein, the CEO and majority shareholder, has loaned funds to the Company from time to time to cover general operating expenses. These loans are evidenced by unsecured, non-interest-bearing notes, payable upon demand. During the nine months ended September 30, 2023, the Company’s majority shareholder loaned an additional $44,700 to the Company. The amounts due to Mr. Goldstein are $1,056,695 and $874,679 as of September 30, 2023, and December 31, 2022, respectively.

Line of Credit

Line of Credit	9 Months Ended
	Sep. 30, 2023
Line of Credit [Abstract]
Line of Credit	Note 8 – Line of Credit As of September 30, 2023, the Company had four lines of credit with a maximum borrowing amount of $400,000 with interest ranging from 5.5% to 11.5% and are unsecured. As of September 30, 2023, and December 31, 2022, the amounts outstanding under these lines of credit were $311,273 and $307,321, respectively.

Leases

Leases	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Leases	Note 9 – Leases The Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company must discount lease payments based on an estimate of its incremental borrowing rate which is based on the interest rate of similar debt outstanding. The Company leases its current facilities from Gold Team Inc., a company owned by the Company’s CEO, which owns both the Canoga Park, CA and Milford, Ohio locations. The leases expired on April 30, 2023, and the Company exercised its renewal option for an additional 12 months. The new lease is not more than 12 months; therefore, the disclosures under ASC 842 are not required. Future minimum lease payments under this agreement for the twelve months ending December 31, 2022, is $168,000. Effective January 1, 2019, the Company adopted the provision of ASC 842 Leases. The lease expense for the nine months ended September 30, 2023, and 2022 was $126,000 and $126,000, respectively. The cash paid under operating leases during the nine months ended September 30, 2023, and 2022 was $0 and $0, respectively. As of September 30, 2023, the weighted average remaining lease terms were 0.1 years, and the weighted average discount rate was 8%.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 10 - Commitments and Contingencies From time to time the Company may be a party to litigation matters involving claims against the Company. Management believes that there are no known or potential matters that would have a material effect on the Company’s financial position or results of operations.

Shareholders_ Equity

Shareholders’ Equity	9 Months Ended
	Sep. 30, 2023
Shareholders’ Equity [Abstract]
Shareholders’ Equity	Note 11 – Shareholders’ Equity Common Stock During the nine months ended September 30, 2023, the Company issued: ● 2,600,000 shares of common stock to its Directors and President, valued at $239,080; and ● 800,000 shares of common stock valued at $120,000 in satisfaction of convertible debt and interest; and ● 1,785,300 shares of common stock to consultants for services rendered valued at $176,813. The fair value was determined based on the Company’s stock price on the grant date; and ● 771,845 and 517,391 shares of common stock in a cashless exercise of 1,500,000 and 1,000,000 warrants, respectively. During the nine months ended September 30, 2022, the Company issued: ● 625,000 shares of common stock valued at $100,019 in relation to the debt that was obtained; ● 400,000 shares of common stock valued at $80,000 in satisfaction of convertible debt and interest; ● 785,805 shares of common stock to consultants for services rendered valued at $158,670. The fair value was determined based on the Company’s stock price on the grant date Warrants The following table summarizes the activity related to warrants: Weighted Weighted Average Average Remaining Aggregate Warrants Exercise Contractual Intrinsic Outstanding Price Life Value Outstanding, December 31, 2022 2,500,000 $ 0.11 2.32 $ - Granted - - - Forfeited - Exercised 2,500,000 $ 0.11 Outstanding, September 30, 2023 - $ - - $ - Exercisable, September 30, 2023 - $ - - $ - The above warrants contain a down-round provision that requires the exercise price to be adjusted if the Company sells shares of common stock below the current exercise price. During the nine months ended September 30, 2023, Company issued shares of common stock for $0.11 therefore, X = Y(A-B) A where: X= the number of warrant shares to be issued (771,845 and 517,391) Y= the number of warrant shares the holder elects to purchase (1,500,000 and 1,000,000) A= the Market Price ($0.309 and $0.23) B= Exercise Price ($0.15 and $0.111)

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Segment Reporting	Note 12 – Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company has two reportable segments: Optron and Overhoff. Optron is located in Canoga Park, California and Overhoff is located in Milford, Ohio. The assets and operations of the Company’s recent acquisition of the assets of Electronic Control Concepts are included with Overhoff in the table below. The assets and operations of the Company’s subsidiary, Cali From Above, are through March 3, 2023, which is the date the Company divested its interest in Cali and are included with Optron in the table below. The following tables summarize the Company’s segment information for the three and nine months ended September 30, 2023, and 2022: Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Sales Optron $ 183,048 $ 96,883 $ 278,812 $ 176,096 Overhoff 410,454 505,918 1,309,197 1,348,788 Corporate - 14,633 - 14,633 $ 593.502 $ 617,434 $ 1,588,009 $ 1,539,517 Gross profit Optron $ 96,004 $ 99,609 $ 56,324 $ 143,818 Overhoff 369,770 104,169 879,693 549,991 Corporate - 8,185 - 8,185 $ 465,775 $ 211,963 $ 936,017 $ 701,994 Income (loss) from operations Optron $ (176,388 ) $ (181,632 ) $ (655,738 ) $ (753,482 ) Overhoff 317,383 (147,632 ) 350,726 (269,926 ) Corporate (102,647 ) (154,155 ) (634,553 ) (378,236 ) $ (73,563 ) $ (483,419 ) $ (969,565 ) $ (1,401,644 ) Interest Expenses Optron $ 918 $ 10,626 $ 10,808 $ 14,482 Overhoff 5,697 2,533 14,288 4,617 Corporate 21,180 18,551 45,539 18,551 $ 27,795 $ 31,710 $ 70,635 $ 37,650 Net income (loss) Optron $ (184,846 ) $ (304,277 ) $ (674,086 ) $ (767,964 ) Overhoff 316,487 (138,165 ) 341,438 (274,543 ) Corporate (891,703 ) (213,380 ) (1,963,466 ) (629,236 ) $ (760,002 ) $ (655,822 ) $ (2,296,114 ) $ (1,671,743 ) As of 2023 As of Total Assets Optron $ 756,186 $ 1,021,817 Overhoff 2,323,528 2,037,988 Corporate 23,581 48,932 $ 3,103,296 $ 3,108,737 Goodwill Optron $ - $ - Overhoff 570,176 570,176 Corporate - - $ 570,176 $ 570,176

Geographical Sales

Geographical Sales	9 Months Ended
	Sep. 30, 2023
Geographical Sales [Abstract]
Geographical Sales	Note 13 - Geographical Sales The geographical distribution of the Company’s sales for the three and nine months ended September 30, 2023, and 2022 is as follows: Three Months Ended September 30, 2023 2022 Geographical sales North America $ 570,420 $ 446,810 Asia 11,034 115,340 Other 12,048 55,284 $ 593,502 $ 617,434 Nine Months Ended September 30, 2023 2022 Geographical sales North America $ 1,389,587 $ 1,032,051 Asia 136,254 311,125 Other 62,168 196,341 $ 1,588,009 $ 1,539,517

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 14 – Related Party Transactions The Company leases its current facilities from Gold Team Inc., a company owned by the Company’s CEO, which owns both the Canoga Park, CA and Milford, Ohio locations. Rent expense for the nine months ended September 30, 2023, and 2022 was $126,000 and $126,000, respectively. As of September 30, 2023, and December 31, 2022, amounts payable to Gold Team Inc. in connection with the above leases amount to $406,000 and $280,000, respectively (See Note 9). The lease is currently on a month-to-month basis. In addition, as of September 30, 2023, and December 31, 2022, the Company had accrued compensation payable to its majority shareholder of $650,000 and $500,000, respectively. Also see Note 7.

Deconsolidation of Subsidiary

Deconsolidation of Subsidiary	9 Months Ended
	Sep. 30, 2023
Deconsolidation of Subsidiary [Abstract]
Deconsolidation of Subsidiary	Note 15 – Deconsolidation of Subsidiary On March 3, 2023, the Company divested itself of its wholly owned subsidiary, Cali From Above, through a Membership Interest Purchase Agreement with the Company’s President and Chief Executive Officer, Robert Goldstein. Consideration received by the Company was 65,000,000 shares of Averox, Inc. (OTC:AVRI), resulting in the Company owning 26% of the issued and outstanding shares of common stock of AVRI. The Company considered the guidance under ASC 810-10-40 in determining the accounting treatment for the transaction and it was determined that the fair value of the 65,000,000 shares received on March 3, 2023, was $2,539, which was the fair value of the assets transferred upon deconsolidation by the Company. Additionally, this method was used due to there being no active trading by Averox on the date of the transaction. Also at closing, the Company and Cali From Above signed a Cooperation Agreement whereby the Company holds exclusive sourcing and manufacturing rights for Cali From Above products, thus making Cali From Above a new customer of the Company. Upon deconsolidation, the Company recorded a loss of $2,539, reflecting the value of $2,539 in cash in Cali From Above.

Concentrations

Concentrations	9 Months Ended
	Sep. 30, 2023
Concentrations [Abstract]
Concentrations	Note 16 – Concentrations Two customers accounted for 29%, 25%, and 16% of the Company’s sales for the nine months ended September 30, 2023, and two customers accounted for 35% and 25% of the Company’s sales for the nine months ended September 30, 2022. No vendors accounted for more than 10% of the Company’s purchases for the nine months ended September 30, 2023, and 2022.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 17 – Subsequent Events Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date the financial statements were available to be issued and has determined that no material subsequent events exist other than the following: On October 15, 2023, the Company issued 210,000 to a consultant for services at a fair value of $13,650, or $0.065 per share. On October 16, 2023, the Company entered into a note payable with a third party for $125,000, of which the Company received $122,500 after an origination fee of $2,500. The note accrues non-annualized interest of 20%, or $25,000. The note is to be repaid in 52 weekly payments of $2,885, beginning on October 20, 2023. The note provides for monthly incremental prepayment discounts if satisfied in full prior to the due date. On October 25, 2023, the Company issued 50,000 shares to a consultant for services at a fair value of $3,450, or $0.069 per share. On October 27, 2023, the Company issued 450,000 shares of common stock in satisfaction of $47,619 in principal, $581 in interest, and $1,750 in fees on a convertible note payable. The shares were issued at $0.111 per share. On November 8, 2023, the Company amended its convertible promissory notes originally entered into on May 5, 2022, and October 10, 2022, by extending the maturity dates of both notes to May 5, 2024. In connection and for consideration thereof, the Company issued a common stock purchase warrant for the purchase of 1,000,000 shares of common stock. The exercise price of the warrant is $0.06, subject to adjustments, including but not limited to cashless exercise, and expire on November 8, 2028.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2023
Basis Presentation [Abstract]
Interim financial statements	Interim financial statements The unaudited interim financial statements included herein, presented in accordance with United States generally accepted accounting principles and stated in US dollars, have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosure normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosure is adequate to make the information presented not misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with the financial statements of the Company for the year ended December 31, 2022, and notes thereto included in the Company’s annual report on Form 10-K filed on May 12, 2023. The Company follows the same accounting policies in the preparation of interim reports. Results of operations for the interim period are not indicative of annual results.
Going Concern	Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company recorded a net loss of $2,296,114 for the nine months ended September 30, 2023, and had an accumulated deficit of $17,428,994 as of September 30, 2023, which raises substantial doubt about its ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries which include Optron, Overhoff Technology Corporation (“Overhoff”), and its wholly owned subsidiary, Electronic Control Concepts (“ECC”), have been prepared in conformity with accounting principles generally accepted in the United States of America. All significant intercompany transactions and balances have been eliminated.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include cash on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. There were no cash equivalents as of September 30, 2023, and December 31, 2022.
Concentration of credit risk	Concentration of credit risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents. The Company places its cash with high quality financial institutions and at times may exceed the FDIC insurance limit. The Company has not and does not anticipate incurring any losses related to this credit risk.
Accounts Receivable	Accounts Receivable The Company maintains reserves for potential credit losses for accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded based on the Company’s historical collection history. Allowance for doubtful accounts as of September 30, 2023, and December 31, 2022, were $5,000 and $5,000, respectively.
Inventories	Inventories Inventories are valued at the lower of cost (determined primarily by the average cost method) or net realizable value. Management compares the cost of inventories with the net realizable value and allowance is made for writing down their inventories to net realizable value, if lower. As of September 30, 2023, and December 31, 2022, there was no allowance for slow moving or obsolete inventory. The Company periodically assessed its inventory for slow moving and/or obsolete items. If any are identified an appropriate allowance for those items is made and/or the items are deemed to be impaired.
Property and Equipment	Property and Equipment Property and Equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of equipment is provided using the straight-line method for substantially all assets with estimated lives as follows: Furniture and fixtures 5 years Leasehold improvement Lesser of lease life or economic life Equipment 5 years Computers and software 5 years
Long-Lived Assets	Long-Lived Assets The Company applies the provisions of Accounting Standards Codification (“ASC”) Topic 360, Property, Plant, and Equipment
Goodwill	Goodwill Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. The entire goodwill balance in the accompanying financial statements resulted from the Company’s acquisition of Overhoff Technology Corporation in 2006. The Company complies with ASC 350, Goodwill and Other Indefinite Lived Intangible Assets
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of September 30, 2023, and December 31, 2022, there are no derivative liabilities associated with our convertible notes payable.
Investments	Investments The Company accounts for investments in equity securities without a readily determinable fair value at cost, minus impairment. If the Company identifies observable price changes in orderly transactions for the identical or a similar investment of the same issuer, the Company measures the equity security at fair value as of the date that the observable transaction occurred (“the measurement alternative”) in accordance with ASC 321. The Company accounts for investments for which it owns 20% or more, but less than 50% on the equity method in accordance with ASC 323.
Fair Value of Financial Instruments	Fair Value of Financial Instruments For certain of the Company’s financial instruments, including cash, accounts receivable, accounts payable, accrued liabilities, customer deposits, and line of credit, the carrying amounts approximate their fair values due to their short maturities. In addition, the Company has a note payable to a shareholder that the carrying amount also approximates fair value.
Revenue Recognition	Revenue Recognition Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers Topic 606 Topic 606. Topic 605, Revenue Recognition Revenues from product sales are recognized under Topic 606 ● executed contracts with the Company’s customers that it believes are legally enforceable; ● identification of performance obligations in the respective contract; ● determination of the transaction price for each performance obligation in the respective contract; ● allocation the transaction price to each performance obligation; and ● recognition of revenue only when the Company satisfies each performance obligation. These five elements, as applied to each of the Company’s revenue category, is summarized below: ● Product sales - revenue is recognized when the Company performs its obligations under the contracts it has with its customers to deliver products at an agreed upon price and it is generally when the control of the product has been transferred to the customer. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as customer deposits. Sales returns and allowances was $0 for the nine months ended September 30, 2023, and 2022. The Company provides a one-year warranty on all sales. Warranty expense for the nine months ended September 30, 2023, and 2022 was insignificant. The Company does not provide unconditional right of return, price protection or any other concessions to its customers. See Notes 12 and 13 for disclosures of revenue disaggregated by geographical area and product line.
Customer Deposits	Customer Deposits Customer deposits represent cash paid to the Company by customers before the product has been completed and shipped.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The adoption had no effect on the Company’s consolidated financial statements.
Stock-Based Compensation	Stock-Based Compensation The Company records stock-based compensation in accordance with FASB ASC Topic 718, “ Compensation – Stock Compensation
Basic and Diluted Earnings Per Share	Basic and Diluted Earnings Per Share Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share
Segment Reporting	Segment Reporting FASB ASC Topic 280, Segment Reporting
Related Parties	Related Parties The Company accounts for related party transactions in accordance with ASC 850, Related Party Disclosures
Reclassifications	Reclassifications Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or stockholders’ equity.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity

Basis Presentation (Tables)

Basis Presentation (Tables)	9 Months Ended
	Sep. 30, 2023
Basis Presentation [Abstract]
Schedule of Estimated Useful Lives of Property and Equipment	Depreciation of equipment is provided using the straight-line method for substantially all assets with estimated lives as follows: Furniture and fixtures 5 years Leasehold improvement Lesser of lease life or economic life Equipment 5 years Computers and software 5 years

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2023
Inventories [Abstract]
Schedule of Inventory	Inventories at September 30, 2023 and December 31, 2022 consisted of the following: September 30, December 31, 2023 2022 Raw materials $ 968,162 $ 1,244,880 Work in Progress 91,069 409,637 Finished goods 1,004,885 370,127 Total inventories $ 2,064,116 $ 2,024,664

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2023
Property and Equipment [Abstract]
Schedule of Property and Equipment	The following are the details of the property and equipment at September 30, 2023 and December 31, 2022: September 30, December 31, 2023 2022 Furniture and fixtures $ 148,033 $ 148,033 Leasehold Improvements 50,091 50,091 Equipment 237,418 237,418 Computers and software 39,482 39,482 475,024 475,024 Less accumulated depreciation (470,866 ) (468,523 ) Property and equipment, net $ 4,158 $ 6,501

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Payable [Abstract]
Schedule of Future Maturities of All Notes Payable	Future maturities of all notes payable, net of any debt discounts as of September 30, 2023, are as follows: Years ended December 31, 2023 $ 716,525 2024 - 2025 - 2026 - 2027 - Thereafter - $ 716,525

Shareholders_ Equity (Tables)

Shareholders’ Equity (Tables)	9 Months Ended
	Sep. 30, 2023
Shareholders’ Equity [Abstract]
Schedule of Activity Related to Warrants	The following table summarizes the activity related to warrants: Weighted Weighted Average Average Remaining Aggregate Warrants Exercise Contractual Intrinsic Outstanding Price Life Value Outstanding, December 31, 2022 2,500,000 $ 0.11 2.32 $ - Granted - - - Forfeited - Exercised 2,500,000 $ 0.11 Outstanding, September 30, 2023 - $ - - $ - Exercisable, September 30, 2023 - $ - - $ -

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Schedule of Company’s Segment Information	The following tables summarize the Company’s segment information for the three and nine months ended September 30, 2023, and 2022: Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Sales Optron $ 183,048 $ 96,883 $ 278,812 $ 176,096 Overhoff 410,454 505,918 1,309,197 1,348,788 Corporate - 14,633 - 14,633 $ 593.502 $ 617,434 $ 1,588,009 $ 1,539,517 Gross profit Optron $ 96,004 $ 99,609 $ 56,324 $ 143,818 Overhoff 369,770 104,169 879,693 549,991 Corporate - 8,185 - 8,185 $ 465,775 $ 211,963 $ 936,017 $ 701,994 Income (loss) from operations Optron $ (176,388 ) $ (181,632 ) $ (655,738 ) $ (753,482 ) Overhoff 317,383 (147,632 ) 350,726 (269,926 ) Corporate (102,647 ) (154,155 ) (634,553 ) (378,236 ) $ (73,563 ) $ (483,419 ) $ (969,565 ) $ (1,401,644 ) Interest Expenses Optron $ 918 $ 10,626 $ 10,808 $ 14,482 Overhoff 5,697 2,533 14,288 4,617 Corporate 21,180 18,551 45,539 18,551 $ 27,795 $ 31,710 $ 70,635 $ 37,650 Net income (loss) Optron $ (184,846 ) $ (304,277 ) $ (674,086 ) $ (767,964 ) Overhoff 316,487 (138,165 ) 341,438 (274,543 ) Corporate (891,703 ) (213,380 ) (1,963,466 ) (629,236 ) $ (760,002 ) $ (655,822 ) $ (2,296,114 ) $ (1,671,743 ) As of 2023 As of Total Assets Optron $ 756,186 $ 1,021,817 Overhoff 2,323,528 2,037,988 Corporate 23,581 48,932 $ 3,103,296 $ 3,108,737 Goodwill Optron $ - $ - Overhoff 570,176 570,176 Corporate - - $ 570,176 $ 570,176

Geographical Sales (Tables)

Geographical Sales (Tables)	9 Months Ended
	Sep. 30, 2023
Geographical Sales [Abstract]
Schedule of Geographical Distribution	The geographical distribution of the Company’s sales for the three and nine months ended September 30, 2023, and 2022 is as follows: Three Months Ended September 30, 2023 2022 Geographical sales North America $ 570,420 $ 446,810 Asia 11,034 115,340 Other 12,048 55,284 $ 593,502 $ 617,434 Nine Months Ended September 30, 2023 2022 Geographical sales North America $ 1,389,587 $ 1,032,051 Asia 136,254 311,125 Other 62,168 196,341 $ 1,588,009 $ 1,539,517

Basis Presentation (Details)

Basis Presentation (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Basis Presentation [Abstract]
Net loss	$ (2,296,114)
Accumulated deficit	(17,428,994)		$ (15,130,867)
Allowance for doubtful accounts	$ 5,000		$ 5,000
Investments percentage	20%
Equity method percentage	50%
Sales returns and allowances	$ 0	$ 0
Tax benefit, percentage	50%
Warrants outstanding (in Shares)	0		2,500,000
Share of warrants (in Shares)	5,591,929
Reportable segments	2

Basis Presentation (Details) -

Basis Presentation (Details) - Schedule of Estimated Useful Lives of Property and Equipment	9 Months Ended
	Sep. 30, 2023
Furniture and fixtures [Member]
Schedule of Estimated Useful Lives of Property and Equipment [Line Items]
Property and equipment	5 years
Leasehold improvement [Member]
Schedule of Estimated Useful Lives of Property and Equipment [Line Items]
Leasehold improvement	Lesser of lease life or economic life
Equipment [Member]
Schedule of Estimated Useful Lives of Property and Equipment [Line Items]
Property and equipment	5 years
Computers and software [Member]
Schedule of Estimated Useful Lives of Property and Equipment [Line Items]
Property and equipment	5 years

Inventories (Details)

Inventories (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Inventories [Abstract]
Inventory reserve	$ 0	$ 0

Inventories (Details) - Schedul

Inventories (Details) - Schedule of Inventory - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Schedule of Inventories [Abstract]
Raw materials	$ 968,162	$ 1,244,880
Work in Progress	91,069	409,637
Finished goods	1,004,885	370,127
Total inventories	$ 2,064,116	$ 2,024,664

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Property and Equipment [Abstract]
Depreciation expense	$ 2,343	$ 2,135

Property and Equipment (Detai_2

Property and Equipment (Details) - Schedule of Property and Equipment - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 475,024	$ 475,024
Less accumulated depreciation	(470,866)	(468,523)
Property and equipment, net	4,158	6,501
Furniture and fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	148,033	148,033
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	50,091	50,091
Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	237,418	237,418
Computers and software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 39,482	$ 39,482

Investments (Details)

Investments (Details) - USD ($)				9 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Aug. 03, 2018	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Apr. 30, 2019
Investments (Details) [Line Items]
Percentage of ownership interest			10%
Investment amount							$ 500,000
Shares of common stock (in Shares)				517,391
Ownership interest in MIFTEC							0.56%
Grapheton’s common stock (in Shares)				2,552
Shares issued (in Shares)				1,452
Stock value				$ 601,227
Additional shares issued (in Shares)				1,100
Out payment				$ 192,500
Ownership, percentage				35.80%
Equity investment				$ 8,059
Equity investment amount					$ 0
Shares received (in Shares)				65,000,000
Common Stock [Member]
Investments (Details) [Line Items]
Shares of common stock (in Shares)				771,845
Shares of common stock				$ 235,000
Equity Method Investments Ownership Percentage [Member]
Investments (Details) [Line Items]
Ownership percentage				26%
MIFTEC
Investments (Details) [Line Items]
Investment amount			$ 500,000
Shares of common stock (in Shares)			300,000
Common stock valued			$ 594,000
Interest Payable		$ 10,000
Acquisition of manufacturing		$ 1,084,000
Investment for impairment	$ 9,000
Carrying value of investment				$ 1,000		$ 1,000
MIFTEC | Ownership Interest [Member]
Investments (Details) [Line Items]
Percentage of ownership interest			10%
Investment interest rate			10%
MIFTEC [Member]
Investments (Details) [Line Items]
Shares of common stock (in Shares)							500,000
Investment for impairment	$ 499,000
Carrying value of investment				$ 1,000		$ 1,000
Investment, description				the Company also entered into a Cooperative Agreement with MIFTI whereby the Company acquired certain exclusive manufacturing and supply rights, including thermonuclear fusion-powered reactor for production of electricity per MIFTI designs in return for $500,000, of which $100,000 is payable upon signing, $200,000 within four months of the agreement and $200,000 within nine months of the agreement. The $500,000 is an option to buy a 10% interest in MIFTI for $2,700,000, if completed within 24 months of the agreement date. If the options expire, MIFTI shall issue the Company 500,000 shares of common stock and rescind all other exclusive rights contained in the agreement.
Grapheton, Inc [Member]
Investments (Details) [Line Items]
Shares of common stock (in Shares)				858,896
Additional shares issued (in Shares)				1,121,071
Common stock value (in Shares)				633,405

Notes Payable (Details)

Notes Payable (Details) - USD ($)				9 Months Ended
	Oct. 10, 2022	May 05, 2022	Apr. 15, 2021	Sep. 30, 2023	Dec. 31, 2022	Dec. 26, 2020
Notes Payable Details [Line Items]
Notes payable				$ 5,272	$ 5,272
Repaid amount				0
Accrues interest rate per share (in Dollars per share)						$ 10.89
Balance amount owed				0
Issuance stock warrants		$ 750,000
Debt discounts		$ 550,538		1,275,316
Additional debt discount				578,712
Unamortized debt discount	$ 200,488			0
Interest rate percentage	16%	16%
Stock warrants amount	$ 375,000
Total remaining unamortized debt discount				71,754
Accrued Interest [Member]
Notes Payable Details [Line Items]
Accrued interest rate			5%
Interest Payments [Member]
Notes Payable Details [Line Items]
Principal and interest payments			$ 4,518
Accrues Interest [Member]
Notes Payable Details [Line Items]
Accrued interest rate	5%	5%
Warrant [Member]
Notes Payable Details [Line Items]
Additional debt discount				$ 589,545

Notes Payable (Details) - Sched

Notes Payable (Details) - Schedule of Future Maturities of All Notes Payable	Sep. 30, 2023 USD ($)
Notes Payable [Abstract]
2023	$ 716,525
2024
2025
2026
2027
Thereafter
Total	$ 716,525

Note Payable to Shareholder (De

Note Payable to Shareholder (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Note Payable to Shareholder [Abstract]
Majority shareholder loaned an additional	$ 44,700
Due to related parties	$ 1,056,695	$ 874,679

Line of Credit (Details)

Line of Credit (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Line of Credit (Details) [Line Items]
Line of credit	$ 311,273	$ 307,321
Line of Credit [Member]
Line of Credit (Details) [Line Items]
Line of credit maximum borrowing amount	$ 400,000
Line of Credit [Member] | Minimum [Member]
Line of Credit (Details) [Line Items]
Interest rate on line of credit	5.50%
Line of Credit [Member] | Maximum [Member]
Line of Credit (Details) [Line Items]
Interest rate on line of credit	11.50%

Leases (Details)

Leases (Details) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Leases (Details) [Line Items]
Operating leases payment	$ 0	$ 0	$ 168,000
Operating Lease, Expense	$ 126,000	$ 126,000
Weighted average remaining lease terms	1 month 6 days
Weighted average discount rate	8%

Shareholders_ Equity (Details)

Shareholders’ Equity (Details) - USD ($)	3 Months Ended			9 Months Ended
	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Shareholders’ Equity (Details) [Line Items]
Shares of common stock				517,391
Common stock shares					400,000
Common stock valued (in Dollars)				$ 120,000	$ 80,000
Warrants exercised (in Dollars)				1,000,000
Exercise price (in Dollars)				$ 2,013
Common shares issued				517,391
Common Stock [Member]
Shareholders’ Equity (Details) [Line Items]
Shares of common stock				771,845
Common stock shares	800,000	400,000
Common shares issued				771,845
Common shares issued			625,000
Maximum [Member]
Shareholders’ Equity (Details) [Line Items]
Issued shares of common stock per share (in Dollars per share)				$ 0.14
warrants (in Dollars)				$ 0.111
Common shares issued				517,391
Holder elects to purchase				1,000,000
Market Price (in Dollars per share)				$ 0.23
Minimum [Member]
Shareholders’ Equity (Details) [Line Items]
Warrant exercise price (in Dollars per share)				$ 0.11
warrants (in Dollars)				$ 0.15
Common shares issued				771,845
Holder elects to purchase				1,500,000
Market Price (in Dollars per share)				$ 0.309
Convertible Debt [Member]
Shareholders’ Equity (Details) [Line Items]
Common stock valued					625,000
Relation debts (in Dollars)					$ 100,019
Warrants [Member]
Shareholders’ Equity (Details) [Line Items]
Warrants exercised (in Dollars)				$ 1,500,000
Warrant exercise price (in Dollars per share)				$ 0.11
warrants (in Dollars)				$ 1,500,000
Exercised [Member]
Shareholders’ Equity (Details) [Line Items]
warrants (in Dollars)				$ 1,000,000
Convertible Debt [Member]
Shareholders’ Equity (Details) [Line Items]
Common stock shares				800,000
Consultants [Member]
Shareholders’ Equity (Details) [Line Items]
Shares of common stock				1,785,300
Directors and president, valued (in Dollars)				$ 176,813
Common stock valued					785,805
Relation debts (in Dollars)					$ 158,670
Directors and President [Member]
Shareholders’ Equity (Details) [Line Items]
Shares of common stock				2,600,000
Directors and president, valued (in Dollars)				$ 239,080

Shareholders_ Equity (Details)

Shareholders’ Equity (Details) - Schedule of Activity Related to Warrants - Warrant [Member]	9 Months Ended
	Sep. 30, 2023 USD ($) $ / shares shares
Shareholders’ Equity (Details) - Schedule of Activity Related to Warrants [Line Items]
Warrants Outstanding, at Beginning	2,500,000
Weighted Average Exercise Price, at Beginning (in Dollars per share) | $ / shares	$ 0.11
Weighted Average Remaining Contractual Life, at Beginning	2 years 3 months 25 days
Aggregate Intrinsic Value, at Beginning (in Dollars) | $
Warrants Outstanding, Granted
Weighted Average Exercise Price ,Granted (in Dollars per share) | $ / shares
Weighted Average Remaining Contractual Life, Granted
Warrants Outstanding, Forfeited
Warrants Outstanding, Exercised	2,500,000
Weighted Average Exercise Price , Exercised (in Dollars per share) | $ / shares	$ 0.11
Warrants Outstanding, at Ending
Weighted Average Exercise Price, at Ending (in Dollars per share) | $ / shares
Weighted Average Remaining Contractual Life, at Ending
Aggregate Intrinsic Value, at Ending (in Dollars) | $
Warrants Outstanding, Exercisable
Weighted Average Exercise Price, Exercisable (in Dollars per share) | $ / shares
Weighted Average Remaining Contractual Life, Exercisable
Aggregate Intrinsic Value, Exercisable (in Dollars) | $

Segment Reporting (Details)

Segment Reporting (Details)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Number of reportable segments	2

Segment Reporting (Details) - S

Segment Reporting (Details) - Schedule of Company’s Segment Information - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Segment Reporting Information [Line Items]
Sales	$ 593.502	$ 617,434	$ 1,588,009	$ 1,539,517
Gross profit	465,775	211,963	936,017	701,994
Income (loss) from operations	(73,563)	(483,419)	(969,565)	(1,401,644)
Interest Expenses	27,795	31,710	70,635	37,650
Net income (loss)	(760,002)	(655,822)	(2,296,114)	(1,671,743)
Total Assets	3,103,296		3,103,296		$ 3,108,737
Goodwill	570,176		570,176		570,176
Optron [Member] | Segments [Member]
Segment Reporting Information [Line Items]
Sales	183,048	96,883	278,812	176,096
Gross profit	96,004	99,609	56,324	143,818
Income (loss) from operations	(176,388)	(181,632)	(655,738)	(753,482)
Interest Expenses	918	10,626	10,808	14,482
Net income (loss)	(184,846)	(304,277)	(674,086)	(767,964)
Total Assets	756,186		756,186		1,021,817
Goodwill
Overhoff [Member] | Segments [Member]
Segment Reporting Information [Line Items]
Sales	410,454	505,918	1,309,197	1,348,788
Gross profit	369,770	104,169	879,693	549,991
Income (loss) from operations	317,383	(147,632)	350,726	(269,926)
Interest Expenses	5,697	2,533	14,288	4,617
Net income (loss)	316,487	(138,165)	341,438	(274,543)
Total Assets	2,323,528		2,323,528		2,037,988
Goodwill	570,176		570,176		570,176
Corporate [Member] | Segments [Member]
Segment Reporting Information [Line Items]
Sales		14,633		14,633
Gross profit		8,185		8,185
Income (loss) from operations	(102,647)	(154,155)	(634,553)	(378,236)
Interest Expenses	21,180	18,551	45,539	18,551
Net income (loss)	(891,703)	$ (213,380)	(1,963,466)	$ (629,236)
Total Assets	23,581		23,581		48,932
Goodwill

Geographical Sales (Details) -

Geographical Sales (Details) - Schedule of Geographical Distribution - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Geographical sales
Geographical sales	$ 593,502	$ 617,434	$ 1,588,009	$ 1,539,517
North America [Member]
Geographical sales
Geographical sales	570,420	446,810	1,389,587	1,032,051
Asia [Member]
Geographical sales
Geographical sales	11,034	115,340	136,254	311,125
Other [Member]
Geographical sales
Geographical sales	$ 12,048	$ 55,284	$ 62,168	$ 196,341

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Related Party Transactions (Details) [Line Items]
Rent expense	$ 126,000	$ 126,000
Accrued compensation payable	650,000		$ 500,000
Gold Team Inc [Member]
Related Party Transactions (Details) [Line Items]
Payable to related party	$ 406,000		$ 280,000

Deconsolidation of Subsidiary (

Deconsolidation of Subsidiary (Details)	Mar. 03, 2023 USD ($) shares
Deconsolidation of Subsidiary (Details) [Line Items]
Consideration received (in Shares) | shares	65,000,000
Equity Method Investments Ownership Percentage [Member]
Deconsolidation of Subsidiary (Details) [Line Items]
Ownership percentage	26%
Averox Inc [Member]
Deconsolidation of Subsidiary (Details) [Line Items]
Consideration received (in Shares) | shares	65,000,000
Fair value of assets transferred	$ 2,539
Company recorded loss	2,539
Cash	$ 2,539

Concentrations (Details)

Concentrations (Details)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Purchase [Member]
Concentrations (Details) [Line Items]
Concentration percentage	10%	10%
Customers One [Member] | Sales [Member]
Concentrations (Details) [Line Items]
Concentration percentage	29%	35%
Customers Two [Member] | Sales [Member]
Concentrations (Details) [Line Items]
Concentration percentage	25%	25%
Customer Three [Member] | Sales [Member]
Concentrations (Details) [Line Items]
Concentration percentage	16%

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	Oct. 27, 2023	Oct. 25, 2023	Oct. 20, 2023	Oct. 16, 2023	Oct. 15, 2023	Nov. 08, 2023
Subsequent Events (Details) [Line Items]
Share issued (in Shares)		50,000			210,000
Consultant for services		$ 3,450			$ 13,650
Consultant for services, per share (in Dollars per share)		$ 0.069			$ 0.065
Note payable				$ 125,000
Received amount				122,500
Origination fee				$ 2,500
Non-annualized interest, percentage				20%
Non-annualized interest				$ 25,000
Weekly payments			$ 2,885
Issued shares (in Shares)	450,000
Principal amount	$ 47,619
Principal interest	581
Convertible note payable	$ 1,750
Issuance of per share (in Dollars per share)	$ 0.111
Purchase warrant (in Shares)						1,000,000
Warrant [Member]
Subsequent Events (Details) [Line Items]
Price of warrant						$ 0.06